Clinical Trial Details

Trial ID: L0895
Source ID: IRCT2014042612438N6
Associated Drug: Hepatoheal
Title: The effect of hepatoheal tablet on liver enzymes of patients with non alcoholic fatty liver and its comparison with vitamin E
Acronym: --
Status: Not Recruiting
Study Results: No Results Available
Results: --
Conditions: non alcoholic fatty liver. <br>Nonalcoholic fatty liver disease (NAFLD);Nonalcoholic fatty liver disease (NAFLD)
Interventions: Intervention 1: intervention:hepatoheal tablet+placebo pearl.2 times in day for 4 months. Intervention 2: control:vitamin E pearl+ placebo tablet.2 times in day for 4 months. Intervention 3: control:hepatoheal tablet+vitamin E pearl.2 times in day for 4 m
Outcome Measures: ALT. Timepoint: beginning and end of study. Method of measurement: blood test.;AST. Timepoint: beginning and end of study. Method of measurement: blood test.;ALP. Timepoint: beginning and end of study. Method of measurement: blood test.HOMA-IR. Timepoint: beginning and end of study. Method of measurement: blood test.
Sponsor/Collaborators: Barij Research Center of Medicinal Herbs
Gender: All
Age: 18 years139 years
Phases: Phase 2/Phase 3
Enrollment: 90
Study Type: interventional
Study Designs: Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment.
Start Date: 18/08/2014
Completion Date: --
Results First Posted: --
Last Update Posted: 22 February 2018
Locations: Iran (Islamic Republic of)
URL: http://en.irct.ir/trial/12494